This study aims to learn if new treatments can help people with **Interstitial Lung Disease (ILD)** caused by **Systemic Sclerosis (SSc)**, a condition where the skin and organs become hard. The treatments will be compared to a **placebo** (a harmless pill with no medicine) over 52 weeks to see if they improve lung function. Eligible participants must be 18 or older and have SSc with lung issues confirmed by a special scan (HRCT). You need to have had SSc symptoms for 7 years or less and meet certain health conditions.
Key Points:
- The study lasts for 52 weeks and involves regular check-ups.
- There are specific health criteria needed to join.
- Participants cannot have certain other health conditions or treatments.
How understandable was the trial content above?
Hard to understand
Easy to understand